Short‐ and long‐acting synthetic pentasaccharides

This publication has 26 references indexed in Scilit:

• Ability of Recombinant Factor VIIa to Reverse the Anticoagulant Effect of the Pentasaccharide Fondaparinux in Healthy Volunteers
  Circulation, 2002
• Absence of Interaction of Fondaparinux Sodium with Aspirin and Piroxicam in Healthy Male Volunteers
  Clinical Pharmacokinetics, 2002
• Fondaparinux Sodium Is Not Metabolised in Mammalian Liver Fractions and Does Not Inhibit Cytochrome P450-Mediated Metabolism of Concomitant Drugs
  Clinical Pharmacokinetics, 2002
• The Pharmacokinetics of Fondaparinux Sodium in Healthy Volunteers
  Clinical Pharmacokinetics, 2002
• Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee Surgery
  New England Journal of Medicine, 2001
• Absence of cross-reactivity of SR90107A/ORG31540 pentasaccharide with antibodies to heparin-PF4 complexes developed in heparin-induced thrombocytopenia
  Blood Coagulation & Fibrinolysis, 1997
• SR 90107A/Org 31540, a Novel Anti‐Factor Xa Antithrombotic Agent
  Cardiovascular Drug Reviews, 1997
• A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis
  New England Journal of Medicine, 1996
• Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at Home
  New England Journal of Medicine, 1996
• A prospective study of the incidence of deep‐vein thrombosis within a defined urban population
  Journal of Internal Medicine, 1992